tgen Archives

SHC’s Von Hoff honored for cancer advances

dan-von-hoff

In association with its 50th anniversary, the American Society of Clinical Oncology (ASCO) has named Daniel D. Von Hoff, M.D., FACP, one of ASCO’s 50 Oncology Luminaries, celebrating 50 doctors who over the past half-century have significantly advanced cancer care. Dr. Von Hoff is Chief Scientific Officer for Scottsdale Healthcare’s Virginia G. Piper Cancer Center… Read More →

LaneTerralever Wins Best in Class

81270218

Phoenix-based LaneTerralever earned three 2013 Interactive Media Awards (IMA) including a Best in Class award for Thunderbird for Good, and two Outstanding Achievement awards – one for Honeywell Aerospace and the other for Translational Genomics Research Institute (TGen). IMA is a competition designed to elevate the standards of excellence on the Internet, and is presented… Read More →

TGen identifies key lung cancer enabler

cancer

Researchers at the Translational Genomics Research Institute (TGen) have discovered a protein, Mcl-1, that helps enable one of the most common and deadly types of cancer to survive radiation and drug treatments. Non-small cell lung cancer (NSCLC) makes up about 85 percent of the nearly 160,000 Americans expected to die this year from lung cancer,… Read More →

TGen’s Von Hoff inducted into Joshua Lederberg Society

dan-von-hoff

Dr. Daniel D. Von Hoff, Distinguished Professor and Physician-In-Chief of the Translational Genomics Research Institute (TGen), was inducted into the Joshua Lederberg Society for his work in developing the drug Abraxane for advanced pancreatic cancer patients. The Lederberg Society is named for the late Dr. Joshua Lederberg, a Nobel Prize laureate and leader in bacterial… Read More →

The Voice of Development: Joyce Grossman, AAED

Joyce Grossman 1 © Lillian Reid

Joyce Grossman became executive director of AAED in 2011. She has a B.A. from the University of California-Davis and a M.P.A. from California State University, Sacramento. Prior to joining AAED, Grossman was a deputy director with the City of Phoenix. She helped in attracting the International Genomics Consortium/Translational Genomics Research Institute to Phoenix. AZRE caught… Read More →

TGen’s Zenhausern is named an NAI fellow

bioscience

Dr. Frederic Zenhausern, a Professor at the Translational Genomics Research Institute (TGen) and developer of a rapid DNA processor, has been named to the Fellows of the National Academy of Inventors (NAI). Zenhausern, Ph.D., MBA, will be inducted into the NAI Fellows by Deputy U.S. Commissioner for Patents Andy Faile, from the U.S. Patent and… Read More →

TGen's Zenhausern is named an NAI fellow

bioscience

Dr. Frederic Zenhausern, a Professor at the Translational Genomics Research Institute (TGen) and developer of a rapid DNA processor, has been named to the Fellows of the National Academy of Inventors (NAI). Zenhausern, Ph.D., MBA, will be inducted into the NAI Fellows by Deputy U.S. Commissioner for Patents Andy Faile, from the U.S. Patent and… Read More →

TGen-Barrow-PCH study brain injuries

brain

In an effort to lower medical costs, identify patients at risk for injury, and speed patient recovery, scientists will attempt to identify a molecular signal that indicates severity of brain-injury during a $4 million, five-year federal grant to Barrow Neurological Institute at St. Joseph’s Hospital and Medical Center, Phoenix Children’s Hospital and the Translational Genomics… Read More →

TGen-led study finds link to Parkinson’s disease

stem.cell

The absence of a protein called SMG1 could be a contributing factor in the development of Parkinson’s disease and other related neurological disorders, according to a study led by the Translational Genomics Research Institute (TGen). The study screened 711 human kinases (key regulators of cellular functions) and 206 phosphatases (key regulators of metabolic processes) to… Read More →

Quayle elected to TGen Foundation Board

quayle

Former U.S. Vice President Dan Quayle, who served under President George H.W. Bush from 1989-93, was elected today to the Board of Directors of the TGen Foundation, the philanthropic arm of the non-profit Translational Genomics Research Institute (TGen). Vice President Quayle attended grade school and high school in Phoenix and Scottsdale and he and his… Read More →

17th U.S. Surgeon General joins TGen advisory panel

bioscience

The 17th Surgeon General of the United States and President of Canyon Ranch Institute Richard H. Carmona, M.D., M.P.H., FACS, today joined the Translational Genomics Research Institute (TGen) advisory committee on rare childhood disorders. Dr. Carmona’s role on the National Advisory Committee for TGen’s Center for Rare Childhood Disorders (the Center) will be to help… Read More →

TGen identifies genes linked to unhealthy liver function

stem.cell

A groundbreaking study of nearly 2,300 extremely obese diabetes patients, led by the Translational Genomics Research Institute (TGen), has identified genes associated with unhealthy liver function. This is believed to be the nation’s first large-scale genome-wide association study in overweight patients with diabetes. Results of the study, done in conjunction with the Geisinger Health System,… Read More →

TGen researchers uncover root of myeloma relapse

stem.cell

Researchers have discovered why multiple myeloma, a difficult to cure cancer of the bone marrow, frequently recurs after an initially effective treatment that can keep the disease at bay for up to several years. Working in collaboration with colleagues at Princess Margaret Hospital in Toronto, researchers from Mayo Clinic in Arizona and the Translational Genomics… Read More →

TGen Foundation plans two major fundraising events

medical.research

The Translational Genomics Research Institute (TGen) Foundation plans two climate-appropriate fundraising events — “Shop for a Cause” while it’s still hot, and “stepNout” when it cools off this fall. Mark your calendars for TGen’s 8th annual stepNout Run/Walk/Dash set for Nov. 3 at Kiwanis Park, 6111 S. All-America Way, in Tempe. Nearly 1,000 participants are… Read More →